5 ESSENTIAL ELEMENTS FOR TRASTUZUMAB SEQUENCE

One of the more beneath-investigated “driving forces” involved in trastuzumab resistance is PTEN. Nagata et al. (2004) described which the loss of PTEN was noticed in 36% of HER2-good primary breast tumor specimens from sufferers with phase IV ailment. Additionally, Additionally they confirmed that individuals with PTEN-deficient tumors experie